— Know what they know.
Not Investment Advice
Also trades as: GXGX (NASDAQ) · $vol 6M · GXGXW (NASDAQ) · $vol 0M · CELUW (NASDAQ) · $vol 0M

CELU NASDAQ

Celularity Inc.
1W: +15.9% 1M: -14.0% 3M: +100.0% YTD: +32.2% 1Y: -21.6% 3Y: -31.3% 5Y: -97.9%
$1.60
+0.22 (+15.94%)
 
Weekly Expected Move ±15.4%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 49 · $46.3M mcap · 19M float · 0.714% daily turnover · Short 68% of daily vol

Balance Sheet Trends

Total Assets
$133M -7.8% ▼
5Y CAGR: -23.9%
Total Liabilities
$124M +20.3% ▲
5Y CAGR: -20.2%
Shareholders Equity
$9M -78.4% ▼
5Y CAGR: -42.3%
Cash & Investments
$738K +225.1% ▲
5Y CAGR: -51.7%
Total Debt
$69M +5.2% ▲
5Y CAGR: +19.7%
Net Debt
$68M +4.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$54M$37M$14M$227K$738K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$54M$37M$14M$227K$738K
Net Receivables$7M$5M$7M$12M$14M
Inventory$4M$10M$5M$6M$5M
Other Current Assets$873K$2K$1M$0$857K
Total Current Assets$72M$59M$34M$20M$21M
Property, Plant & Equip.$90M$91M$89M$79M$72M
Goodwill & Intangibles$249M$246M$241M$18M$17M
Long-Term Investments$15M$15M$15M$10M$10M
Other Non-Current Assets$5M$3M$23M$27M$13M
Total Non-Current Assets$359M$355M$368M$124M$112M
Total Assets$431M$414M$401M$144M$133M
— Liabilities —
Accounts Payable$5M$9M$6M$14M$23M
Short-Term Debt$3M$3M$38M$39M$6M
Deferred Revenue$5M$2M$2M$3M$4M
Other Current Liabilities$8M$8M$14M$8M$2M
Total Current Liabilities$27M$26M$62M$67M$54M
Long-Term Debt$0$0$0$0$36M
Other Non-Current Liab.$350M$259M$110M$6M$5M
Total Non-Current Liabilities$386M$288M$140M$36M$70M
Total Liabilities$412M$315M$202M$103M$124M
— Equity —
Common Stock$1K$12K$15K$19K$2K
Retained Earnings-$564M-$664M-$645M-$842M-$900M
Accumulated OCI$0$0$9K$0-$5K
Total Stockholders Equity$19M$99M$199M$41M$9M
Total Liabilities & Equity$431M$414M$401M$144M$133M
— Key Metrics —
Total Debt$31M$31M$66M$65M$69M
Net Debt-$24M-$6M$52M$65M$68M
Total Investments$15M$15M$15M$10M$10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms